KHIDI

Major Research Areas

Gachon Neuroscience Research Institute

Gachon Neuroscience Research Institute
Major co-development institutes
Siemens (Germany), Harvard Medical School and others
Area of current development
PET-MRI Fusion Imaging System
Critical Technology of GNRI
- High-resolution image latest algorithm
- Development of Core MRI parts

LEE GIL YA Cancer and Diabetes Institute

Major Research Centers
- Diabetes & Metabolic Disease Research Center
- Cancer Research Center
- Center for Regenerative Medicine
- The Korea Mouse Metabolic Phenotyping Center
- Center for Genomics and Proteomics
Goal
Continued study regarding cancer, diabetes mellitus, obesity and
inflammatory diseases
Critical Technology of CDI
- Human Genome analysis, 5th in the world
- Development of new contrast agent for MRI

Bio Research Complex

Scale : 205,793 ㎡
Manage overall process of clinical development, manufacture
facilities, administration, and academic exchange programs
Master Plan
- Build Cutting-edge BINT Cluster
- Place for complex task & academic tie
- Basis for research production

Neuroscience Research Institute
- Founded in 2004
- Initial Investment : 64 billion won
- Infrastructure for superior clinical imaging system
Gil Medical Center
- 12 specialized centers
- Brain and metabolic disease-specialized clinic and research capacity
- Gil medical center affiliated NRI and LCDI
Lee Gil Ya Cancer and Diabetes Institute
- Founded in 2008
- Initial Investment : 67 billion won
- Infrastructure for cancer and metabolic disease research
Open research resources in NRI
- Super resolution imaging system (7T MRI, HRRTPET)
- Fusion imaging system with improved accuracy and precision
- Early diagnosis for nuerodegenerative diseases (Alzheimer’s and Parkinson’s disease) and stroke
- Medical System Twinning project
- Technology transfer between Gil-medical center and Daewong pharmaceutical for cancer MRI
Goal
- IND approval in a year
- Phase 1 entry in 2 years
Open research resources in LCDI
- Fully equipped facilities specialized to cancer and diabetes
- KMMPC: First mouse metabolic phenotyping center in Asia
- NECMD: Efficacy evaluation center for metabolic drugs
- One stop/Conveyer system optimized for efficacy evaluation of metabolic disease therapeutics(https://www.necmd.co.kr)
- Genetically engineered mouse phenotyping for efficacy evaluation of metablic disease therapeutics

<div class="float_wrap agency01_02"> <div class="float_left"> <h2 class="depth2_title">Gachon Neuroscience Research Institute</h2> <ul class="depth2_txt arrow_lstyle"> <li>Gachon Neuroscience Research Institute</li> <li>Major co-development institutes <p>Siemens (Germany), Harvard Medical School and others</p></li> <li>Area of current development <p>PET-MRI Fusion Imaging System</p></li> <li>Critical Technology of GNRI <ul> <li>High-resolution image latest algorithm</li> <li>Development of Core MRI parts</li> </ul></li> </ul></div> <div class="float_right"><img alt="" src="../../resources/images/erd/content/agency01_02_1.jpg"></div></div> <div class="float_wrap02 agency01_02"> <div class="float_left"> <h2 class="depth2_title">LEE GIL YA Cancer and Diabetes Institute</h2> <ul class="depth2_txt arrow_lstyle"> <li>Major Research Centers <ul> <li>Diabetes & Metabolic Disease Research Center</li> <li>Cancer Research Center</li> <li>Center for Regenerative Medicine</li> <li>The Korea Mouse Metabolic Phenotyping Center</li> <li>Center for Genomics and Proteomics</li> </ul></li> <li>Goal <p>Continued study regarding cancer, diabetes mellitus, obesity and<br>inflammatory diseases</p></li> <li>Critical Technology of CDI <ul> <li>Human Genome analysis, 5th in the world</li> <li>Development of new contrast agent for MRI</li> </ul></li> </ul></div> <div class="float_right"><img alt="" src="../../resources/images/erd/content/agency01_02_2.jpg"></div></div> <div class="float_wrap02 agency01_02"> <div class="float_left"> <h2 class="depth2_title">Bio Research Complex</h2> <ul class="depth2_txt arrow_lstyle"> <li>Scale : 205,793 ㎡</li> <li>Manage overall process of clinical development, manufacture<br>facilities, administration, and academic exchange programs</li> <li>Master Plan <ul> <li>Build Cutting-edge BINT Cluster</li> <li>Place for complex task & academic tie</li> <li>Basis for research production</li> </ul></li> </ul></div> <div class="float_right"><img alt="" src="../../resources/images/erd/content/agency01_02_3.jpg"></div></div> <div class="agency01_02_4"> <ul> <li>Neuroscience Research Institute <ul> <li>Founded in 2004</li> <li>Initial Investment : 64 billion won</li> <li>Infrastructure for superior clinical imaging system</li> </ul></li> <li>Gil Medical Center <ul> <li>12 specialized centers</li> <li>Brain and metabolic disease-specialized clinic and research capacity</li> <li>Gil medical center affiliated NRI and LCDI</li> </ul></li> <li>Lee Gil Ya Cancer and Diabetes Institute <ul> <li>Founded in 2008</li> <li>Initial Investment : 67 billion won</li> <li>Infrastructure for cancer and metabolic disease research</li> </ul></li> <li> <h3>Open research resources in NRI</h3> <ul> <li>Super resolution imaging system (7T MRI, HRRTPET)</li> <li>Fusion imaging system with improved accuracy and precision</li> <li>Early diagnosis for nuerodegenerative diseases (Alzheimer’s and Parkinson’s disease) and stroke</li> <li>Medical System Twinning project</li> <li>Technology transfer between Gil-medical center and Daewong pharmaceutical for cancer MRI</li> </ul> <h3>Goal</h3> <ul> <li>IND approval in a year</li> <li>Phase 1 entry in 2 years</li> </ul></li> <li>Open research resources in LCDI <ul> <li>Fully equipped facilities specialized to cancer and diabetes</li> <li>KMMPC: First mouse metabolic phenotyping center in Asia</li> <li>NECMD: Efficacy evaluation center for metabolic drugs</li> <li>One stop/Conveyer system optimized for efficacy evaluation of metabolic disease therapeutics(https://www.necmd.co.kr)</li> <li>Genetically engineered mouse phenotyping for efficacy evaluation of metablic disease therapeutics</li> </ul></li> </ul></div>
Source. Press Ctrl + C to copy it to your clipboard.

KRH Designated Agency

Major Research Areas

Gachon Neuroscience Research Institute

LEE GIL YA Cancer and Diabetes Institute

Bio Research Complex

Open research resources in NRI

Goal